Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study [0.03%]
达雷妥尤单抗为基础的治疗在多发性骨髓瘤及其他浆细胞异常疾病中的临床疗效：全国范围真实世界研究分析
Allison C Y Tso,Wee Joo Chng,Yeow Tee Goh et al.
Allison C Y Tso et al.
Singapore leads Southeast Asia in the routine use of daratumumab for multiple myeloma and other plasma cell dyscrasias. This retrospective review analyzed 112 patients who received daratumumab between 2012 and 2020. Tolerability, and effica...
Andrew P Jallouk,Salyka Sengsayadeth,Bipin N Savani et al.
Andrew P Jallouk et al.
Psychological Impact in Individuals with Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma [0.03%]
意义未明单克隆免疫球蛋白血症及冒烟型多发性骨髓瘤患者的个体心理影响
Tanvi H Patel,Ramya Bachu,Trilok Shrivastava et al.
Tanvi H Patel et al.
In our study of 246 newly diagnosed individuals with MGUS or SMM (115 MGUS, 131 SMM), we found that 19% reported anxiety, with no significant difference between the MGUS and SMM groups (22% vs. 17%). Those with a history of psychiatric diso...
The acceptability of using wearable electronic devices to monitor physical activity of patients with Multiple Myeloma undergoing treatment: a systematic review [0.03%]
多发性骨髓瘤患者治疗期间使用可穿戴电子设备监测身体活动的接受度：系统评价
Tommy Brown,Ann Muls,Charlotte Pawlyn et al.
Tommy Brown et al.
Introduction: Multiple myeloma (MM) is diagnosed in 6,000 people in the UK yearly. A performance status measure, based on the patients' reported level of physical activity, is used to assess patients' fitness for treatmen...
SARS-CoV2 is not just infection but a culprit of donor graft failure post-allogeneic stem cell transplant [0.03%]
SARS-CoV2 不仅是感染 而且是allo-HSCT后供者移植物功能衰竭的元凶
Yoojin Park,Silvia Park,Wichai Chinratanalab et al.
Yoojin Park et al.
Mohamad Mohty,Kanti Rai
Mohamad Mohty
The EMMY longitudinal, cohort study: real-world data to describe multiple myeloma management and outcomes as more therapeutic options emerge [0.03%]
EMMY纵向队列研究：真实世界数据揭示了随着更多治疗选择的出现多发性骨髓瘤的诊治和结局
Olivier Decaux,Ronan Garlantézec,Karim Belhadj-Merzoug et al.
Olivier Decaux et al.
The therapeutic management of patients with multiple myeloma (MM) is complex. Despite substantial advances, MM remains incurable, and management involves cycles of treatment response, disease relapse, and further therapy. Currently, evidenc...
Finn Bo Petersen,Mohamad Mohty,Didier Blaise
Finn Bo Petersen
Shakthi T Bhaskar,Bhagirathbhai Dholaria,Bipin N Savani et al.
Shakthi T Bhaskar et al.
Chimeric antigen receptor (CAR) T-cell therapy has gained wide used across an array of hematologic malignancies. Though CAR T therapy has changed outcomes in the treatment of many malignancies its administration can be complicated by delays...
Junia Melo,Mohamad Mohty
Junia Melo